Protein,Protein_definition,Disease_category,Disease,method,nsnp,OR [95% CI],Pvalue,QTL_type
PTPRM,Receptor-type tyrosine-protein phosphatase mu,Chapter IX Diseases of the circulatory system,I9_HYPTENSPOR,Wald ratio,1,1.09 [1.06-1.12],2.30876949000275e-08,trans
PTPRM,Receptor-type tyrosine-protein phosphatase mu,Chapter IX Diseases of the circulatory system,I9_VARICVEOES,Inverse variance weighted,2,1.08 [1.05-1.11],3.86693344230036e-08,trans
PTPRM,Receptor-type tyrosine-protein phosphatase mu,Chapter XI Diseases of the digestive system,K11_LIVER,Inverse variance weighted,8,1.11 [1.04-1.2],0.00246757918046524,trans
PTPRM,Receptor-type tyrosine-protein phosphatase mu,Chapter XI Diseases of the digestive system,K11_FIBROCHIRLIV,Inverse variance weighted,2,1.09 [1.01-1.17],0.0207983148592863,trans
PTPRM,Receptor-type tyrosine-protein phosphatase mu,Chapter XI Diseases of the digestive system,CHIRHEP_NAS,Inverse variance weighted,2,1.06 [1.01-1.11],0.0281140498360249,trans
PTPRM,Receptor-type tyrosine-protein phosphatase mu,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,Inverse variance weighted,69,1.03 [1-1.05],0.0334976273598111,trans
PTPRM,Receptor-type tyrosine-protein phosphatase mu,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",DM_BCKGRND_RETINA,Inverse variance weighted,3,1 [0.97-1.03],0.956790862268689,trans
PTPRM,Receptor-type tyrosine-protein phosphatase mu,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,Inverse variance weighted,3,1 [0.97-1.03],0.999945958662773,trans
